Related Experiment Videos
Focal segmental glomerulosclerosis in children
Insights
Idiopathic focal segmental glomerulosclerosis (FSGS) in children often leads to kidney failure despite standard treatments. This review explores clinical features, outcomes, and emerging therapies for pediatric FSGS, offering new insights into its causes.
Area of Science:
- Pediatric Nephrology
- Glomerular Diseases
- Renal Pathology
Background:
- Idiopathic focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome in children.
- Unlike minimal change disease, FSGS frequently progresses to end-stage renal disease (ESRD) in pediatric populations.
- Standard proteinuria treatments are often ineffective, increasing complication risks and the likelihood of ESRD.
Purpose of the Study:
- To review the clinical presentation and outcomes of pediatric idiopathic FSGS.
- To evaluate the efficacy of novel therapeutic strategies for managing FSGS in children.
- To explore potential causative factors and provide new insights into the pathogenesis of FSGS.
Main Methods:
- Literature review of clinical studies on pediatric idiopathic FSGS.
- Analysis of treatment responses to standard and emerging therapies.
- Synthesis of current research on the underlying mechanisms of FSGS.
Main Results:
- Pediatric FSGS presents with nephrotic syndrome but has a poorer prognosis than minimal change disease, often leading to renal failure.
- Many patients do not respond adequately to conventional therapies, necessitating exploration of alternative treatments.
- Recurrence of FSGS post-kidney transplantation remains a significant concern.
Conclusions:
- Idiopathic FSGS in children poses a substantial risk for progressive kidney disease and ESRD.
- Newer treatment options show promise but require further investigation for optimal use in pediatric FSGS.
- Understanding the factors contributing to FSGS development is crucial for improving patient outcomes and preventing recurrence.
Abstract:
Idiopathic focal segmental glomerulosclerosis is a histologic diagnosis that usually presents as the nephrotic syndrome but, unlike minimal change disease, often leads to renal failure in children. Standard therapies used to treat the proteinuria are often futile, and thus patients are at risk for the multiple complications resulting from persistent, severe proteinuria. Eventually, end-stage renal failure ensues, and the possibility of the disease recurring in the transplanted renal allograft is worrisome. This report reviews the clinical features and outcomes of idiopathic focal segmental glomerulosclerosis in children, the response to newer treatment options, and new insights into understanding what factors may be involved in causing the disorder.